Clinical trial
Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and…
NCT00405639 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00405639 |
|---|---|
| Title | Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function |
| Official title | To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Asymptomatic Systolic Dysfunction |
| Intervention type | Drug |
| Interventions | Nesiritide, Placebo |
| Enrollment | 37 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | May 1, 2013 |
| First posted | Nov 30, 2006 |
| Last update posted | Mar 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: